Frontpage » 09/27/2012 »

Archive: 09/27/2012

Follow-up lacking for babies after hepatitis B vaccination: CDC

(HealthDay)—Many U.S. babies born to mothers infected with hepatitis B do not receive recommended follow-up testing after vaccination, a new study finds.

Diseases, Conditions, Syndromes created Sep 27, 2012 | popularity not rated yet | comments 0

Hospital observation units could save billions in health costs, study says

(HealthDay)—Wider use of hospital observation units could save the U.S. health care system billions of dollars a year, a new study indicates.

Health created Sep 27, 2012 | popularity 5 / 5 (1) | comments 0

Flu season's approaching so roll up your sleeve

(HealthDay)—The only thing predictable about the flu is its unpredictability, U.S. health officials said Thursday, as they urged virtually all Americans to get vaccinated for the coming season.

Health created Sep 27, 2012 | popularity not rated yet | comments 0

Helicopter heroes save lives

The benefits and cost effectiveness of helicopter transport for severely injured patients is of continued debate. New research published in BioMed Central's open access journal Critical Care shows that for severe blunt trauma ...

Other created Sep 27, 2012 | popularity not rated yet | comments 0

Study highlights the burden of epilepsy in the developing world

The burden of epilepsy in poorer parts of the world could be readily alleviated by reducing the preventable causes and improving access to treatment, according to a review article published today in the Lancet.

Neuroscience created Sep 27, 2012 | popularity not rated yet | comments 0

Physical activity interventions for children have 'little impact'

Physical activity interventions for children have small impact on overall activity levels and consequently the body fat and mass of children, a study published in the British Medical Journal today suggests.

Health created Sep 27, 2012 | popularity not rated yet | comments 0

Myogenes identified for spondyloarthritis synovitis

(HealthDay)—There are disease-specific and inflammation-independent stromal alterations in spondyloarthritis (SpA) synovitis, according to a study published online Sept. 12 in Arthritis & Rheumatism.

Arthritis & Rheumatism created Sep 27, 2012 | popularity 5 / 5 (1) | comments 0

Progesterone test can predict viability of pregnancy

Measuring progesterone levels in women with pain or bleeding during early pregnancy is a useful way to help discriminate between a viable and a non-viable pregnancy, finds a study published in the British Medical Journal to ...

Obstetrics & gynaecology created Sep 27, 2012 | popularity 1 / 5 (1) | comments 0

Over 65s at increased risk of developing dementia with benzodiazepine

Patients over the age of 65 who begin taking benzodiazepine (a popular drug used to treat anxiety and insomnia) are at an approximately 50% increased risk of developing dementia within 15 years compared to never-users, a ...

Alzheimer's disease & dementia created Sep 27, 2012 | popularity not rated yet | comments 0

Arterial stiffness inversely tied to plasma adiponectin levels

(HealthDay)—Arterial stiffness is inversely related to plasma adiponectin levels in young, normotensive patients with type 1 diabetes, according to a study published online Sept. 21 in Diabetes Care.

Diabetes created Sep 27, 2012 | popularity not rated yet | comments 0

Insulin sensitivity lower in adults born preterm

(HealthDay)—Middle-aged adults who were born preterm, even moderately preterm (32 to 36 weeks' gestation), are less insulin sensitive compared with adults who were born at term, according to research published ...

Diabetes created Sep 27, 2012 | popularity not rated yet | comments 0

Choice of psoriasis treatment affects CVD event rates

(HealthDay)—Compared with other anti-psoriatic therapies, systemic anti-inflammatory treatment of patients with severe psoriasis with biologic agents or methotrexate is associated with a lower combined ...

Immunology created Sep 27, 2012 | popularity not rated yet | comments 0

Stivarga approved for advanced colorectal cancer

(HealthDay)—Stivarga (regorafenib) has been approved by the U.S. Food and Drug Administration to treat colorectal cancer that has spread despite prior treatment.

Medications created Sep 27, 2012 | popularity not rated yet | comments 0

What looks like play may really be a science experiment

(HealthDay)—You may think your toddler is just playing in the sand box, but she may really be conducting a sophisticated scientific experiment and learning something new every time she pours out another ...

Psychology & Psychiatry created Sep 27, 2012 | popularity 4.3 / 5 (7) | comments 3 | with audio podcast

In treated MS, early disease activity predicts poor outcome

(HealthDay)—After 15 years of follow-up, patients with relapsing-remitting multiple sclerosis (RRMS) who display disease activity despite treatment with interferon (IFN)β-1a tend to have unfavorable long-term ...

Diseases, Conditions, Syndromes created Sep 27, 2012 | popularity not rated yet | comments 0